UBS Group AG Files 6-K Report
Ticker: IWFL · Form: 6-K · Filed: Oct 1, 2025 · CIK: 1114446
| Field | Detail |
|---|---|
| Company | Ubs Ag (IWFL) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
UBS Group AG filed a routine 6-K on Oct 1st, no major news yet.
AI Summary
UBS Group AG filed a Form 6-K on October 1, 2025, reporting information as of September 30, 2025. The filing pertains to UBS AG, a subsidiary, and includes addresses in Zurich, Switzerland, and Stamford, CT. No specific financial figures or material events were detailed in the provided text.
Why It Matters
This filing indicates ongoing reporting requirements for UBS Group AG and its subsidiary UBS AG with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — The filing is a standard periodic report (6-K) and does not contain information indicating immediate or significant risk.
Key Players & Entities
- UBS Group AG (company) — Registrant
- UBS AG (company) — Subsidiary Registrant
- Bahnhofstrasse 45, 8001 Zurich, Switzerland (location) — Principal executive office address
- 600 Washington Blvd. Stamford, CT 06901 (location) — Mail address for UBS AG
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer may make public in its home country, file with a stock exchange, or distribute to its security holders.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is October 1, 2025.
What period does this report cover?
The conformed period of report is September 30, 2025.
Which entities are listed as registrants in this filing?
UBS Group AG and UBS AG are listed as registrants in this filing.
What are the principal business addresses provided for the registrants?
The principal executive office address for UBS Group AG is Bahnhofstrasse 45, 8001 Zurich, Switzerland. UBS AG lists Bahnhofstrasse 45, 8001 Zurich, Switzerland as an address and also a mail address at 600 Washington Blvd., Stamford, CT 06901.
Filing Stats: 4,740 words · 19 min read · ~16 pages · Grade level 12 · Accepted 2025-10-01 09:29:36
Filing Documents
- tbtfpresotext6k202510.htm (6-K) — 197KB
- 0001610520-25-000099.txt ( ) — 199KB
business
business in the US. And these have proven to be resilient, even in times of financial stress. Moreover, our fundamentally different business model in contrast to Credit Suisse makes similar write-downs of our DTAs highly unlikely. Slide 9 – PVA measures should not be based on business combination accounting Finally, turning to slide 9 on PVAs. Prudential valuation adjustments reflect an uncertainty overlay in a bank's capital relating to difficult-to-value securities and derivatives. The Federal Council justifies stricter treatment of PVAs by referencing the extensive security position write-downs on Credit Suisse's balance sheet at the close of the acquisition. We believe this argumentation is incorrect. The write downs reflected purchase price allocation adjustments that UBS considered appropriate as part of standard acquisition accounting. PVAs are designed to account for valuation uncertainty in ongoing business operations and should therefore be viewed in the context of our Level 3 asset profile. Today, our holdings amount to only one-tenth of what Credit Suisse and UBS reported on a pro-forma basis in 2007. Since 2Q23, through the run-down of our Non-core and Legacy portfolio we have further reduced Level 3 assets by around 60% to 16 billion, which is less than 1% of our total balance sheet. The proposed PVA measures do not reflect the progress UBS has made in substantially reducing the valuation uncertainty on its balance sheet. Finally, a brief word on AT1. AT1 instruments play an essential role in a crisis. The fact that UBS was able to restart AT1 issuances with strong demand soon after the rescue of Credit Suisse is evidence of investor confidence in these instruments, including importantly under the current Swiss regime and notwithstanding Credit Suisse events. We support steps to further strengthen AT1 instruments as an effective recovery tool, provided